JPH04507089A - 安定なアスコルビン酸組成物 - Google Patents
安定なアスコルビン酸組成物Info
- Publication number
- JPH04507089A JPH04507089A JP2506472A JP50647290A JPH04507089A JP H04507089 A JPH04507089 A JP H04507089A JP 2506472 A JP2506472 A JP 2506472A JP 50647290 A JP50647290 A JP 50647290A JP H04507089 A JPH04507089 A JP H04507089A
- Authority
- JP
- Japan
- Prior art keywords
- water
- composition
- carrier
- ascorbic acid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (38)
- 1.水中に約1%(w/v)以上のL−アスコルビン酸と、局部的適用に適する 担体とから基本的に構成され、水と担体との比は1:1以上であり、約3.5以 下のpHを有する局所組成物。
- 2.前記化粧担体は、アルキレングリコールを含む請求の範囲1に記載の組成物 。
- 3.前記アルキレングリコールはプロピレングリコールである請求の範囲2に記 載の組成物。
- 4.前記担体は、アルキレングリコールとヒドロキシアルキルセルロースとの組 合である請求の範囲1に記載の組成物。
- 5.前記アルキレングリコールはプロピレングリコールとヒドロキシアルキルセ ルロースである請求の範囲4に記載の組成物。
- 6.前記水と担体との比は約2:1〜約10:1である請求の範囲1に記載の組 成物。
- 7.前記水と担体との比は約2:1〜約10:1である請求の範囲2に記載の組 成物。
- 8.前記水と担体との比は約2:1〜約10:1である請求の範囲3に記載の組 成物。
- 9.3〜20重重%(w/v)のL−アスコルビン酸と、80〜97%の水と、 局部的適用に適する適する担体とから基本的に構成され、水と担体との比は1: 1以上であり、約3.5以下のpHを有する局所組成物。
- 10.前記担体は、アルキレングリコールとヒドロキシアルキルセルロースとの 組合せである請求の範囲9に記載の組成物。
- 11.前記アルキレングリコールとヒドロキシアルキルセルロースとの比は、3 0:1〜5:1である請求の範囲10に記載の組成物。
- 12.前記アルキレングリコールはプロピレングリコールであり、前記ヒドロキ シアルキルセルロースはヒドロキシプロピルセルロースである請求の範囲11に 記載の組成物。
- 13.水中に約1%(w/v)以上のL−アスコルビン酸と、局部的適用に適す る担体とから基本的に構成され、水と担体との比は1:1以上であり、約3.5 以下のpHを有する局所組成物を適用する工程を具備する、紫外線による皮膚の 損傷を阻止する方法。
- 14.前記局所組成物は、3〜20重量%(w/v)のL−アスコルビン酸と、 80〜97%の水と、担体(v/v)とから基本的に構成される請求の範囲13 に記載の方法。
- 15.前記担体は、アルキレングリコールとヒドロキシアルキルセルロースとを 含む請求の範囲14に記載の方法。
- 16.前記アルキレングリコールはプロピレングリコールであり、前記ヒドロキ シアルキルセルロースはヒドロキシプロピルセルロースである請求の範囲15に 記載の方法。
- 17.前記水と担体との比は約2:1〜約10:1である請求の範囲15に記載 の方法。
- 18.前記水と担体との比は約2:1〜約10:1である請求の範囲16に記載 の方法。
- 19.水中に約1%(w/v)以上のL−アスコルビン酸と、局部的適用に適す る担体と、約0.01〜0.1%の金属キレート剤とから基本的に構成され、水 と担体との比は1:1以上であり、約3.5以下のpHを有する局所組成物。
- 20.前記金属キレート剤は、ジエチレントリアミンペンタ酢酸、エチレンジア ミンジ(o−ヒドロキシフェニル酢酸)、エチレングリコールビス(β−アミノ エチルエーテル)−N,N,N′,N′−テトラ酢酸、及びそれらの組合わせか らなる群から選ばれたものである請求の範囲19に記載の組成物。
- 21.皮膚に請求の範囲1,9又は19に記載の組成物を適用することからなる 皮膚の異常を防止する方法。
- 22.皮膚に請求の範囲1,9又は19に記載の組成物を適用することからなる 皮膚の異常を治療する方法。
- 23.前記皮膚の異常は、紫外線の照射により生ずる請求の範囲21に記載の方 法。
- 24.前記皮膚の異常は、紫外線の照射により生ずる請求の範囲21に記載の方 法。
- 25.前記皮膚の異常は、皮膚の炎症である請求の範囲21に記載の方法。
- 26.前記皮膚の異常は、皮膚の炎症である請求の範囲22に記載の方法。
- 27.創傷を受けた後、皮膚に請求の範囲1,9又は19に記載の組成物を適用 することからなる創傷の治癒速度を増加させる方法。
- 28.皮膚に請求の範囲1,9又は19に記載の組成物を適用することからなる 、皮膚の紫外線照射障害による皮膚の新生物の出現を減少させる方法。
- 29.pHが約2.5以下である請求の範囲1,9又は19に記載の組成物。
- 30.前記水は、蒸留水、脱イオン水、及び蒸留脱イオン水からなる群から選ば れたものである請求の範囲1に記載の組成物。
- 31.pHが約2.5以下である請求の範囲30に記載の組成物。
- 32.5〜10重重%(w/v)のL−アスコルビン酸と、90〜95%の水と 、局部的適用に適する適する担体とから基本的に構成され、水と担体との比は1 :1以上であり、約3.5以下のpHを有する局所組成物。
- 33.前記担体は、アルキレングリコールとヒドロキシアルキルセルロースとの 組合せである請求の範囲32に記載の組成物。
- 34.前記アルキレングリコールとヒドロキシアルキルセルロースとの比は、3 0:1〜5:1である請求の範囲33に記載の組成物。
- 35.前記アルキレングリコールはプロピレングリコールであり、前記ヒドロキ シアルキルセルロースはヒドロキシプロビルセルロースである請求の範囲34に 記載の組成物。
- 36.前記水は、蒸留水、脱イオン水、及び蒸留脱イオン水からなる群から選ば れたものである請求の範囲32に記載の組成物。
- 37.前記組成物は皮膚用組成物であり、前記担体は皮膚用担体である請求の範 囲1,9又は19に記載の組成物。
- 38.請求の範囲1,9又は19に記載の組成物を目に適用することからなる目 の異常を治療する方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/339,488 US5140043A (en) | 1989-04-17 | 1989-04-17 | Stable ascorbic acid compositions |
US339,488 | 1989-04-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04507089A true JPH04507089A (ja) | 1992-12-10 |
JP3708540B2 JP3708540B2 (ja) | 2005-10-19 |
Family
ID=23329228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50647290A Expired - Lifetime JP3708540B2 (ja) | 1989-04-17 | 1990-04-16 | 安定なアスコルビン酸組成物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5140043A (ja) |
EP (1) | EP0486499B1 (ja) |
JP (1) | JP3708540B2 (ja) |
AT (1) | ATE156355T1 (ja) |
AU (1) | AU647699B2 (ja) |
CA (1) | CA2054189C (ja) |
DE (1) | DE69031219T2 (ja) |
DK (1) | DK0486499T3 (ja) |
ES (1) | ES2104605T3 (ja) |
HK (1) | HK1001834A1 (ja) |
WO (1) | WO1990012572A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0940545A (ja) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | アスコルビン酸を含有する安定組成物 |
JPH0940543A (ja) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | 水過敏性の化粧および/または皮膚科学的活性剤を含有する安定な組成物 |
JPH09309833A (ja) * | 1996-05-22 | 1997-12-02 | Toyo Hakko:Kk | 活性酸素抑制組成物及びその製造方法並びに血圧抑制剤 |
JP2003520775A (ja) * | 1999-07-16 | 2003-07-08 | インダストリア エ コメルシオ デ コスメティコス ナチュラ リミタダ | 酸化防止化合物及び水性組成物を安定化する方法 |
JP2012054306A (ja) * | 2010-08-31 | 2012-03-15 | Tokyo Electron Ltd | 半導体装置の製造方法 |
JP2013227264A (ja) * | 2012-04-27 | 2013-11-07 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
WO2019189742A1 (ja) * | 2018-03-30 | 2019-10-03 | ロート製薬株式会社 | アスコルビン酸及び/又はその塩を含有する外用組成物 |
WO2020067132A1 (ja) * | 2018-09-25 | 2020-04-02 | ロート製薬株式会社 | アスコルビン酸及び/又はその塩を含有する外用組成物 |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622690A (en) * | 1990-04-05 | 1997-04-22 | Nurture, Inc. | Seed-derived proteinaceous compositions for reduction of sunburn cell formation |
AU662505B2 (en) * | 1990-12-06 | 1995-09-07 | Leslie Binshyang Soong | Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes |
US5308621A (en) * | 1991-02-18 | 1994-05-03 | Commonwealth Scientific And Industrial Research Organisation | Ascorbic acid composition and transdermal administration method |
US5523077A (en) * | 1992-02-06 | 1996-06-04 | Yale University | Composition and method for whitening skin |
ATE196599T1 (de) * | 1993-01-19 | 2000-10-15 | Nicholas V Dr Perricone | Mittel zur topischen anwendung auf der haut zur behandlung und/oder zur verhütung von, durch strahlen verursachten hautschäden |
US5516793A (en) * | 1993-04-26 | 1996-05-14 | Avon Products, Inc. | Use of ascorbic acid to reduce irritation of topically applied active ingredients |
US5759548A (en) * | 1993-11-30 | 1998-06-02 | Lxr Biotechnology Inc. | Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
US5455035A (en) * | 1994-01-13 | 1995-10-03 | Elizabeth Arden Company, Division Of Conopco, Inc. | Clear two-phase cosmetic composition |
US5935584A (en) * | 1994-01-13 | 1999-08-10 | Elizabeth Arden Company | Vitamin C delivery system |
FR2718018B1 (fr) * | 1994-04-05 | 1996-04-26 | Oreal | Composition cosmétique et/ou dermatologique à support hydrophile et vitamine C mélangeables extemporanément. |
US5470874A (en) * | 1994-10-14 | 1995-11-28 | Lerner; Sheldon | Ascorbic acid and proanthocyanidine composition for topical application to human skin |
EP0729746A1 (en) * | 1995-02-28 | 1996-09-04 | Unilever Plc | Vitamin C delivery system |
US5843411A (en) * | 1997-02-06 | 1998-12-01 | Topix Pharmaceuticals Inc. | Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use |
US5750123A (en) * | 1996-06-28 | 1998-05-12 | Chesebrough-Pond's Co., Division Of Conopco, Inc. | Vitamin C delivery system |
US6593456B1 (en) * | 1996-11-06 | 2003-07-15 | The Regents Of The University Of California | Tumor necrosis factor receptor releasing enzyme |
US20050191661A1 (en) * | 1996-11-06 | 2005-09-01 | Tetsuya Gatanaga | Treatment of inflammatory disease by cleaving TNF receptors |
ATE403714T1 (de) | 1996-11-06 | 2008-08-15 | Univ California | Tumor necrosis factor rezeptor abspaltendes enzym,dessen zubereitungen und verwendungen |
US5877209A (en) * | 1996-11-07 | 1999-03-02 | Yunis; Adel A. | Hair follicle protective formulations |
SE9604610D0 (sv) * | 1996-12-16 | 1996-12-16 | Noviscens Ab | Medical composition |
US5906918A (en) * | 1997-02-07 | 1999-05-25 | Health Research Inc. | Compositions and methods for measurement of oxidative DNA damage |
US6495532B1 (en) * | 1997-03-19 | 2002-12-17 | Sky High, Llc | Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof |
US6037481A (en) * | 1997-08-08 | 2000-03-14 | Industria E Comercio De Cosmeticos Natura Ltda | Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment |
US6197317B1 (en) | 1997-08-11 | 2001-03-06 | Marvin E. Klein | Composition and method for the treatment of skin |
US5981578A (en) * | 1997-09-15 | 1999-11-09 | Alexandrides; Ariadne | Increased solubilization and stable cosmetic preparations of ascorbic acid |
US6132737A (en) * | 1997-09-29 | 2000-10-17 | Revlon Consumer Products Corporation | Method for reducing sunburn cell formation with cosmetic compositions containing ascorbic acid |
US6685965B1 (en) | 1997-10-22 | 2004-02-03 | Industria E Comercio De Cosmeticos Natura Ltda. | Process for stabilizing levogyre ascorbic acid (laa), a stable aqueous laa composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment |
US6194452B1 (en) | 1997-11-07 | 2001-02-27 | Howard Murad | Stable pharmaceutical compositions including ascorbic acid and methods of using same |
US6036946A (en) * | 1997-12-24 | 2000-03-14 | Shaklee Corporation | Methods for protecting skin from damaging effects of ultraviolet light |
US5980925A (en) * | 1997-12-30 | 1999-11-09 | Ethicon, Inc. | High glycerin containing anti-microbial cleansers |
US6110966A (en) * | 1998-02-20 | 2000-08-29 | Medi-Cell Laboratories, Inc. | Triple action complex |
US6962904B1 (en) * | 1998-03-13 | 2005-11-08 | Connective Tissue Imagineering | Elastin peptide analogs and uses thereof |
US6809075B1 (en) | 2000-05-30 | 2004-10-26 | Connective Tissue Imagineering Llc | Elastin peptide analogs and uses of same incombination with skin enhancing agents |
US6949528B1 (en) | 1998-03-18 | 2005-09-27 | Goddard John G | Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
US6703030B2 (en) | 1998-06-16 | 2004-03-09 | Marvin E. Klein | Amino fruit acid composition and method for the treatment of skin |
US6146664A (en) * | 1998-07-10 | 2000-11-14 | Shaklee Corporation | Stable topical ascorbic acid compositions |
US6103267A (en) * | 1998-07-27 | 2000-08-15 | Sunsmart, Inc. | Stabilized ascorbic acid, composition, and method of use |
US6207694B1 (en) | 1998-07-27 | 2001-03-27 | Howard Murad | Pharmaceutical compositions and methods for managing scalp conditions |
US6299889B1 (en) † | 1998-09-10 | 2001-10-09 | Avon Products, Inc. | Stable ascorbic acid preparation for topical use |
US6110477A (en) * | 1998-10-30 | 2000-08-29 | Topix Pharmaceuticals Inc. | Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use |
US6777389B1 (en) | 1998-11-19 | 2004-08-17 | Connective Tissue Imagineering Llc | Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides |
KR100297347B1 (ko) * | 1998-12-09 | 2001-08-07 | 이현순 | 안정화된l-아스코르빈산을함유하는유중수형에멀젼화장료조성물및그의제조방법 |
US7816402B2 (en) * | 1999-03-19 | 2010-10-19 | Bioderm, Inc. | Compositions and methods for the treatment of skin |
US6217914B1 (en) | 1999-03-19 | 2001-04-17 | Bioderm, Inc. | Ascorbic acid composition and method for treatment of aging or damaged skin |
US6087393A (en) | 1999-06-10 | 2000-07-11 | Igen, Inc. | Stabilized vitamin C formulations |
US20060063738A1 (en) * | 2000-02-28 | 2006-03-23 | Sky High, Llc | Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof |
US7101563B1 (en) | 2000-03-03 | 2006-09-05 | Australian Importers, Ltd. | Micronized vitamin C formulation |
WO2001066092A1 (en) * | 2000-03-03 | 2001-09-13 | Australian Importers, Ltd. | Micronized vitamin c formulation |
US20050003023A1 (en) * | 2002-06-28 | 2005-01-06 | Meisner Lorraine Faxon | Topical composition for the treatment of psoriasis and related skin disorders |
US6440465B1 (en) | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
CN1189159C (zh) * | 2000-05-05 | 2005-02-16 | 欧莱雅 | 含水溶性美容活性组分水性核的微胶囊及含其的组合物 |
US6794362B1 (en) * | 2000-05-30 | 2004-09-21 | Connective Tissue Imagineering Llc | Asparagine containing elastin peptide analogs |
JP4043942B2 (ja) | 2000-09-08 | 2008-02-06 | ヴィヴィアー・カナダ・インコーポレーテッド | 安定化されたアスコルビン酸溶液;その使用;その調製方法;およびそれを含む製剤 |
US6576248B1 (en) | 2000-09-11 | 2003-06-10 | Avon Products, Inc. | Pigmented vitamin C composition |
US6583184B1 (en) | 2000-11-27 | 2003-06-24 | Avon Products, Inc. | Compositions having comfrey and methods for reducing retinoid-induced skin irritation |
KR100836032B1 (ko) * | 2002-03-26 | 2008-06-09 | (주)아모레퍼시픽 | L-아스코빌산 함유 다중공 고분자 마이크로캡슐, 이의제조방법 및 이를 함유하는 화장료 조성물 |
US7241808B2 (en) * | 2002-05-01 | 2007-07-10 | Marvin Klein | Composition for treatment of skin and method for stabilizing the composition |
US7482116B2 (en) * | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
KR100879133B1 (ko) | 2002-12-23 | 2009-01-19 | 주식회사 엘지생활건강 | 비수유화 미백 화장료 조성물 및 그의 제조방법 |
ES2325590T3 (es) * | 2004-01-13 | 2009-09-09 | L'oreal Usa Creative, Inc. | Composiciones de acido ascorbico estabilizadas y procedimientos para las mismas. |
US7566693B2 (en) * | 2005-02-22 | 2009-07-28 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
US8114829B2 (en) * | 2005-02-22 | 2012-02-14 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
WO2006096973A1 (en) * | 2005-03-16 | 2006-09-21 | Dna Genotek Inc. | Compositions and method for storage of nucleic acid from bodily fluids |
US8642578B2 (en) * | 2005-03-29 | 2014-02-04 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
CA2623725A1 (en) * | 2005-09-30 | 2007-04-12 | Omp, Inc. | Stable ascorbic acid compositions |
BRPI0619596B8 (pt) * | 2005-12-09 | 2021-06-22 | Dna Genotek Inc | sistema de recipiente para o armazenamento liberável de líquido, método para combinar líquido com amostra biológica e kit para a coleta e armazenamento de amostra. |
US20070269534A1 (en) * | 2006-02-02 | 2007-11-22 | Ramirez Jose E | Methods of treating skin to enhance therapeutic treatment thereof |
US20070178058A1 (en) * | 2006-02-02 | 2007-08-02 | Ramirez Jose E | Methods of using stable ascorbic acid compositions |
US20070225360A1 (en) * | 2006-03-22 | 2007-09-27 | L'oreal | Anti-aging composition containing phloretin |
US20080057138A1 (en) * | 2006-09-06 | 2008-03-06 | Telford Holdings Ltd. | Restorative skin cream |
US8415389B2 (en) * | 2007-01-31 | 2013-04-09 | John E. Kulesza | Polyphenol-based composition, and methods and systems for its preparation |
US8491212B2 (en) * | 2008-03-17 | 2013-07-23 | Laboratoire Naturel Paris, Llc | Multi-functional applicator |
US8881894B2 (en) * | 2008-08-21 | 2014-11-11 | Sonovia Holdings Llc | Multiple-compartment applicator |
US8034363B2 (en) * | 2008-12-11 | 2011-10-11 | Advanced Technologies And Regenerative Medicine, Llc. | Sustained release systems of ascorbic acid phosphate |
US20110166222A1 (en) * | 2010-01-05 | 2011-07-07 | Kaplan David L | Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same |
US9068694B2 (en) | 2010-09-22 | 2015-06-30 | Philip J. Gordon Consultants, Inc. | Method of controlling by-products of vitamin C degradation and improving package integrity shelf life |
MX347611B (es) | 2011-06-19 | 2017-05-04 | Abogen Inc | Dispositivos, soluciones y metodos para recoleccion de muestras. |
US20150272924A1 (en) * | 2012-11-08 | 2015-10-01 | Summa Health System | Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing |
JP6997222B2 (ja) | 2017-06-23 | 2022-01-17 | ザ プロクター アンド ギャンブル カンパニー | 皮膚の外観を改善するための組成物及び方法 |
EP3817717A1 (en) | 2018-07-03 | 2021-05-12 | The Procter & Gamble Company | Method of treating a skin condition |
CN112638166B (zh) * | 2018-08-09 | 2024-05-03 | 不二制油集团控股株式会社 | 油脂组合物 |
DE102018008512A1 (de) | 2018-10-27 | 2020-04-30 | Ilma biochem GmbH | Herstellung, Zusammensetzung und Anwendung von Zubereitungen in einer Zweikammer-Auftragungsvorrichtung zur Neutralisierung und Inaktivierung von oxidierenden, ätzenden und reizenden Chemikalien auf der Haut |
FR3090330B1 (fr) | 2018-12-20 | 2020-12-04 | Oreal | Composition aqueuse comprenant des capsules à base d’huile gélifiée contenant un actif sensible à l’oxygène |
WO2021049775A1 (ko) * | 2019-09-11 | 2021-03-18 | ㈜아모레퍼시픽 | 비타민 c 석출 방지용 첨가제 조성물 |
FR3105735B1 (fr) | 2019-12-26 | 2023-07-07 | Oreal | Composition comprenant de l’acide ascorbique |
EP4157206A1 (en) | 2020-06-01 | 2023-04-05 | The Procter & Gamble Company | Method of improving penetration of a vitamin b3 compound into skin |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
EP4262707A1 (en) | 2020-12-17 | 2023-10-25 | L'oreal | Metal sequestering cosmetic composition |
FR3121357B1 (fr) | 2021-03-31 | 2024-05-03 | Oreal | Composition cosmetique hydroglycolique avec une teneur elevee en principes actifs |
WO2022130291A1 (en) | 2020-12-17 | 2022-06-23 | L'oreal | Hydroglycolic cosmetic composition with a high active content |
FR3118874B1 (fr) | 2021-01-21 | 2024-01-12 | Oreal | Composition cosmétique de séquestration des métaux |
FR3117803B1 (fr) | 2020-12-18 | 2022-12-09 | Oreal | Composition comprenant des gélifiants aqueux, un tensioactif et de l’acide ascorbique |
FR3117847B1 (fr) | 2020-12-18 | 2023-11-24 | Oreal | Composition comprenant des gélifiants aqueux, des tensioactifs et de l’acide ascorbique |
FR3121043B1 (fr) | 2021-03-29 | 2024-03-08 | Oreal | Composition antioxydante stabilisee par un filtre uva organique |
WO2022149055A1 (en) | 2021-01-05 | 2022-07-14 | L'oreal | Organic uva filter-stabilized antioxidant composition |
FR3130603A1 (fr) * | 2021-12-20 | 2023-06-23 | L'oreal | Composition cosmétique aqueuse avec acide ascorbique et urée |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2161651A (en) * | 1934-12-27 | 1939-06-06 | Elliott J Roberts | Manufacture of finely divided precipitates |
US2249903A (en) * | 1935-01-26 | 1941-07-22 | Winthrop Chem Co Inc | Stable aqueous solution of ascorbic acid |
US2400171A (en) * | 1935-09-26 | 1946-05-14 | Frances R Ruskin | Stabilized metal ascorbates |
US2134246A (en) * | 1936-07-09 | 1938-10-25 | Hoffmann La Roche | Stable solutions of ascorbic acid salts of histidine and process for the manufacture of same |
US2140989A (en) * | 1936-07-30 | 1938-12-20 | Winthrop Chem Co Inc | Molecular compounds and a process of preparing them |
US2132662A (en) * | 1937-04-08 | 1938-10-11 | Abbott Lab | Aliphatic amine salts of cevitamic acid |
US2150140A (en) * | 1937-04-24 | 1939-03-07 | Hoffmann La Roche | Derivatives of ascorbic acid having an antiscorbutic action and process for the manufacture of same |
US2297212A (en) * | 1938-02-10 | 1942-09-29 | Gockel Heinrich | Stable vitamin c and process for preparing the same |
US2294937A (en) * | 1938-02-26 | 1942-09-08 | Simon L Ruskin | Cevitamate compound |
US2165184A (en) * | 1938-08-31 | 1939-07-04 | Pfizer Charles & Co | Process for producing ascorbic acid |
US2187467A (en) * | 1939-02-11 | 1940-01-16 | Lilly Co Eli | Cevitamate solution |
US2442461A (en) * | 1944-03-09 | 1948-06-01 | Hoffmann La Roche | Stable solutions of calcium ascorbate |
US2585580A (en) * | 1947-06-12 | 1952-02-12 | Opplt Jan | Stabilizing ascorbic acid with thio-sugars |
US2721161A (en) * | 1951-10-23 | 1955-10-18 | American Home Prod | Ascorbic acid preparation |
US4294852A (en) * | 1973-11-01 | 1981-10-13 | Johnson & Johnson | Skin treating compositions |
US4372874A (en) * | 1976-09-13 | 1983-02-08 | Modrovich Ivan Endre | Stabilization of hydrolysis prone labile organic reagents in liquid media |
US4199469A (en) * | 1978-06-21 | 1980-04-22 | Feldmann Chemie | Composition and method for cleaning drinking water tanks |
US4367157A (en) * | 1979-05-10 | 1983-01-04 | Sherman Laboratories, Inc. | Soft contact lens ambient temperature disinfectant solution containing ascorbic acid or salt thereof |
US4414202A (en) * | 1980-02-19 | 1983-11-08 | Silvetti Anthony N | Composition for treatment of wounds |
US4722936A (en) * | 1983-05-05 | 1988-02-02 | Joseph Jacob | Deodorization vaginal products and catamenials |
US4818521A (en) * | 1985-04-18 | 1989-04-04 | Sunstar Kabushiki Kaisha | Emulsion cosmetic stably containing vitamin C |
US4983382A (en) * | 1987-01-27 | 1991-01-08 | Avon Products, Inc. | Cosmetic preparation incorporating stabilized ascorbic acid |
NZ219636A (en) * | 1987-03-16 | 1989-06-28 | Donald Sinclair Hamilton | Cream containing powdered ascorbate |
US4946671A (en) * | 1987-10-22 | 1990-08-07 | The Procter & Gamble Company | Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent |
US4847071A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
US4954332A (en) * | 1987-10-22 | 1990-09-04 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
US4938969A (en) * | 1988-11-14 | 1990-07-03 | Milor Scientific, Ltd. | Method for the treatment of aging or photo-damaged skin |
JPH06337087A (ja) * | 1993-05-27 | 1994-12-06 | Takasago Thermal Eng Co Ltd | 分岐管取付方法及びボンネットの取付方法 |
-
1989
- 1989-04-17 US US07/339,488 patent/US5140043A/en not_active Expired - Lifetime
-
1990
- 1990-04-16 AU AU55239/90A patent/AU647699B2/en not_active Expired
- 1990-04-16 EP EP90906651A patent/EP0486499B1/en not_active Revoked
- 1990-04-16 AT AT90906651T patent/ATE156355T1/de not_active IP Right Cessation
- 1990-04-16 JP JP50647290A patent/JP3708540B2/ja not_active Expired - Lifetime
- 1990-04-16 CA CA002054189A patent/CA2054189C/en not_active Expired - Lifetime
- 1990-04-16 ES ES90906651T patent/ES2104605T3/es not_active Expired - Lifetime
- 1990-04-16 DE DE69031219T patent/DE69031219T2/de not_active Revoked
- 1990-04-16 DK DK90906651.6T patent/DK0486499T3/da active
- 1990-04-16 WO PCT/US1990/001968 patent/WO1990012572A1/en not_active Application Discontinuation
-
1998
- 1998-02-03 HK HK98100779A patent/HK1001834A1/xx not_active IP Right Cessation
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0940545A (ja) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | アスコルビン酸を含有する安定組成物 |
JPH0940543A (ja) * | 1995-07-25 | 1997-02-10 | L'oreal Sa | 水過敏性の化粧および/または皮膚科学的活性剤を含有する安定な組成物 |
JPH09309833A (ja) * | 1996-05-22 | 1997-12-02 | Toyo Hakko:Kk | 活性酸素抑制組成物及びその製造方法並びに血圧抑制剤 |
JP2003520775A (ja) * | 1999-07-16 | 2003-07-08 | インダストリア エ コメルシオ デ コスメティコス ナチュラ リミタダ | 酸化防止化合物及び水性組成物を安定化する方法 |
JP2012054306A (ja) * | 2010-08-31 | 2012-03-15 | Tokyo Electron Ltd | 半導体装置の製造方法 |
JP2013227264A (ja) * | 2012-04-27 | 2013-11-07 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
WO2019189742A1 (ja) * | 2018-03-30 | 2019-10-03 | ロート製薬株式会社 | アスコルビン酸及び/又はその塩を含有する外用組成物 |
JPWO2019189742A1 (ja) * | 2018-03-30 | 2021-04-01 | ロート製薬株式会社 | アスコルビン酸及び/又はその塩を含有する外用組成物 |
WO2020067132A1 (ja) * | 2018-09-25 | 2020-04-02 | ロート製薬株式会社 | アスコルビン酸及び/又はその塩を含有する外用組成物 |
Also Published As
Publication number | Publication date |
---|---|
DE69031219D1 (de) | 1997-09-11 |
WO1990012572A1 (en) | 1990-11-01 |
US5140043A (en) | 1992-08-18 |
DE69031219T2 (de) | 1998-01-22 |
AU5523990A (en) | 1990-11-16 |
EP0486499B1 (en) | 1997-08-06 |
AU647699B2 (en) | 1994-03-24 |
CA2054189A1 (en) | 1990-10-18 |
EP0486499A4 (en) | 1993-06-16 |
JP3708540B2 (ja) | 2005-10-19 |
EP0486499A1 (en) | 1992-05-27 |
ES2104605T3 (es) | 1997-10-16 |
HK1001834A1 (en) | 1998-07-10 |
DK0486499T3 (da) | 1998-03-16 |
ATE156355T1 (de) | 1997-08-15 |
CA2054189C (en) | 2000-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04507089A (ja) | 安定なアスコルビン酸組成物 | |
EP0584178B1 (en) | Composition and method of enhancing sun tanning | |
Darr et al. | Topical vitamin C protects porcine skin from ultraviolet radiation‐induced damage | |
US5397773A (en) | Photoprotective composition containing yeast extract | |
JP3289975B2 (ja) | 人間の毛髪の白髪化を阻止または抑制するための毛髪および頭皮処理用組成物 | |
CA2366996C (en) | Ascorbic acid composition and method for treatment of aging or damaged skin | |
KR920003574B1 (ko) | 시코륨 인티부스 엘의 지상부 추출물을 함유하는 향장 조성물 | |
CN1838935B (zh) | 单线态氧消除剂及使用它的组合物 | |
CN111643411B (zh) | 一种抗衰老组合物及其应用 | |
JPH07145067A (ja) | 外用薬として使用するアンチ・フリーラジカルを使用した化粧品または医薬品の組成物 | |
JPS6236306A (ja) | 色白化粧料 | |
JPH0826967A (ja) | クロロゲン酸又はその誘導体含有化粧料 | |
JPH07133216A (ja) | 老化防止用皮膚外用剤 | |
US6037481A (en) | Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment | |
CN114224778B (zh) | 一种裂褶多糖的组合物及其制备方法和应用 | |
WO2002081027A1 (en) | An antioxidant composition and a cosmetic or pharmaceutical composition | |
EP2535087A2 (en) | Cosmetic, pharmaceutical or nutraceutical formulations containing antioxidant molecules and polymeric materials | |
JP3596622B2 (ja) | 皮膚老化防止用外用剤 | |
US20070264250A1 (en) | Composition for Skin-Whitening and Wrinkle-Care | |
Bazin et al. | A Laser Flash Photolysis and Pulse Radiolysis Study of Primary Photochemical Processes of Flumequine¶ | |
JP3955103B2 (ja) | 損傷を与えたrna断片を含むサンスクリーン組成物 | |
KR100447533B1 (ko) | 피부미백 및 주름개선용 피부 외용제 조성물 | |
US6602906B1 (en) | Method for delivering ascorbic acid and acetone to the dermal layer of the skin | |
JPH09255548A (ja) | シワ形成抑制剤 | |
CN116236432A (zh) | 一种抗炎淡斑精华液的制备方法及制得的抗炎淡斑精华液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050607 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050804 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090812 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100812 Year of fee payment: 5 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100812 Year of fee payment: 5 |